Clinical trials in Foggia – page 6

121 clinical trials in Foggia, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Foggia at a glance

121

clinical trials

Research sites2

Quick filters

121 trials in Foggia

Open in trial search

Pneumococcal immunisation

Not yet recruiting

Registered drugNo placebo

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
Sponsor:Pfizer Inc.

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

InvestigationalNo placebo

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:ADMILPARANT
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Transitional cell carcinoma metastatic

Not yet recruiting

Registered drugNo placebo

Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma After Second-Line Platinum-Based Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Avelumab
Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica

Contact Research Centre

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ZAMPILIMAB
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ADMILPARANT
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ADMILPARANT
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Pancreatic carcinoma metastatic+1

Not yet recruiting

Registered drug

A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Ponsegromab
Sponsor:Pfizer Inc.

Contact Research Centre

Testing Intralymphatic Allergen Immunotherapy for Teenagers and Adults with Grass Pollen Allergy Causing Hay Fever or Asthma

Registered drug

Italy

Participants:18–64 years · 65+ years
Sponsor:University Of Foggia

Contact Research Centre

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:CSL Behring LLC

Contact Research Centre

Study on Finerenone for Slowing Chronic Kidney Disease Progression in Patients Receiving Standard Care

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Finerenone
Sponsor:The George Institute For Global Health

Contact Research Centre

Ductal adenocarcinoma of pancreas

Not yet recruiting

Registered drugNo placebo

Study Comparing Short-Course and Long-Course Chemotherapy with mFOLFIRINOX or PAXG for Patients with Stage I-III Pancreatic Cancer

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Capecitabine
Sponsor:Associazione Italiana Per Lo Studio Del Pancreas

Contact Research Centre

Prostate cancer

Not yet recruiting

Registered drugNo placebo

Study on Docetaxel and Carboplatin-Docetaxel Combination for Prostate Cancer Patients Progressing After Olaparib Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Azienda Provinciale Per I Servizi Sanitari

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Foggia

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on metastatic cancers and advanced treatment approaches. Studies include investigations of novel therapies for prostate cancer, colorectal cancer, and various forms of leukemia.

Castration-resistant Prostate Cancer
Acute Myeloid Leukemia
HER2+ Colorectal Cancer

Research emphasizes targeted therapies and combination treatments to improve patient outcomes.

02 Neurological Disorders

Comprehensive studies exploring treatments for multiple sclerosis and neurodegenerative conditions. Research includes evaluation of new therapeutic agents and disease-modifying treatments.

Multiple Sclerosis Management
Alzheimer's Disease
Radiologically Isolated Syndrome

Focus on improving cognitive function and disease progression management.

03 Cardiovascular Health

Advanced research into heart failure prevention and cardiovascular disease management. Studies evaluate new therapeutic combinations and preventive strategies.

Heart Failure Prevention
Atrial Fibrillation
Type 2 Diabetes Cardiovascular Outcomes

Emphasis on reducing cardiovascular events and improving patient outcomes.

Back to Italy All countries